slu pp 332 vs retatrutide and together SLU-PP-332 Liquid 25mg/mL Retatrutide + SLU-PP-332 Stack for

Participants receiving tirzepatide achieved greater weight-loss milestones than those receiving semaglutide [3]

People taking placebo lost an average of 6 lbs (or ~2.5% body weight)

If you are losing weight and tolerating the medication well at 1 mg, there is no clinical reason to increase further

These agents include semaglutide (Ozempic for diabetes, Wegovy for obesity), liraglutide (Victoza for diabetes, Saxenda for obesity), dulaglutide (Trulicity, diabetes only), and tirzepatide (Mounjaro for diabetes, Zepbound for obesity)with tirzepatide being a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist

Saturated fats cause insulin resistance in our bodies

GLP-1RAs, such as exendin-4 and liraglutide, can reduce neuroinflammation caused by microglia by encouraging a conversion from the pro-inflammatory M1 subtype towards the anti-inflammatory M2 phenotype